Your browser doesn't support javascript.
loading
In vitro evaluation of meropenem-vaborbactam against clinical CRE isolates at a tertiary care center with low KPC-mediated carbapenem resistance.
Kinn, Patrick M; Chen, Derrick J; Gihring, Thomas M; Schulz, Lucas T; Fox, Barry C; McCreary, Erin K; Lepak, Alexander J.
Afiliação
  • Kinn PM; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Chen DJ; Clinical Labs - Microbiology, UW Health, Madison, WI, USA; Department of Pharmacy, UW Health, Madison, WI, USA.
  • Gihring TM; Clinical Labs - Microbiology, UW Health, Madison, WI, USA.
  • Schulz LT; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Fox BC; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • McCreary EK; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Lepak AJ; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. Electronic address: ajlepak@medicine.wisc.edu.
Diagn Microbiol Infect Dis ; 93(3): 258-260, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30344065
ABSTRACT
The in vitro activity of meropenem-vaborbactam was examined against clinical carbapenem-resistant Enterobacteriaceae isolates collected over 3 years at our medical center. Only 3 KPC-producers were identified. Susceptibility to meropenem-vaborbactam was noted in 15/16 (94%) isolates (MIC90 2 mg/L) that were nonsusceptible to meropenem. Meropenem-vaborbactam may have utility at centers where non-KPC-producers are more frequent.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos Borônicos / Farmacorresistência Bacteriana / Infecções por Enterobacteriaceae / Inibidores de beta-Lactamases / Enterobacteriáceas Resistentes a Carbapenêmicos / Meropeném / Antibacterianos Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos Borônicos / Farmacorresistência Bacteriana / Infecções por Enterobacteriaceae / Inibidores de beta-Lactamases / Enterobacteriáceas Resistentes a Carbapenêmicos / Meropeném / Antibacterianos Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article